NEWS






Bayer buys Vividion Therapeutics for up to $2bn

German chemicals and pharmaceuticals giant Bayer AG announced it acquired US-based biopharmaceuticals company Vividion Therapeutics for up to $2 billion. “Vividion’s platform is able to produce…